JavaScriptの設定を有効にしてからご利用いただきますようお願いいたします。(設定方法) 民営コングロマリット復星国際(00656)の傘下の製薬会社、上海復星医薬は、製品開発や商業化という点で、国内外企業とのビジネス展開に成功してきたが、短期的に ...
-
-
Recent Updates
- China’s Clean Tech Surge Recasts the Climate Fight Across the Developing World
- Review: THE PHANTOM OF THE OPERA at Shanghai Grand Theatre
- Shiseido Advances Hair Regeneration Push in China through Hainan Medical Zone
- Fung Group and Caohejing Chart New China Pathways for Global Expansion
- Novartis and Eastern Air Logistics Explore New Drug Supply Chain Paths in China
- Chinese Intelligent Brands Push Global Ambitions From Wuhu
- China FAW Launches JOYEE N01 Mass Production for Global Orders
- China Hosts Secretive Global Governance Forum as Elites Reemerge
- Lee Backs China Persimmon Exports After 17 Year Break
- Wisconsin Farm Exports Set Record as China Sales Plunge
Blogroll